Migraine sufferers in the U.S. found some relief over the past few years as a handful of new treatments came to market. The additions include a group of injectable drugs that help prevent the painful headaches, as well as a pill, Ubrelvy, which was cleared in late 2019 to alleviate migraines after they start.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,